CSL’s headcount reduction and vaccine spinoff dragged shares down 9.5%, from A$271.32 at market close on 18 August to ...

Robert Kennedy Jr. signs recommendation eliminating mercury-based thimerosal from influenza vaccines, fulfilling anti-vaccine ...

Australian shares are set to open lower this morning after US stocks ended roughly flat overnight, as local traders await ...

Australian shares slipped off their all-time peak on Tuesday, dragged down by biotech major CSL’s steepest fall ...

Novavax, Inc. (NASDAQ:NVAX) is a biotechnology company focused on recombinant protein-based vaccines using nanoparticle and ...

CSL Limited is set to demerge its influenza vaccine division, CSL Seqirus, into a separate ASX-listed entity by the end of ...

Australian biotech giant CSL Ltd on Tuesday announced plans to demerge its influenza vaccine division, CSL Seqirus, and said it will lay off up to 15% of its workforce, after reporting a strong growth ...

New research projects funded to combat avian influenza in swine focus on vaccine development, transmission risks, and biosecurity measures.

The vaccine requires a prescription, which people can obtain by filling out a medical screening questionnaire through the ...

Australian biotech giant CSL said on Tuesday it plans to demerge its influenza vaccine division, CSL Seqirus, into a separately listed company by the end of the financial year 2026, alongside job cuts ...

Yes, the flu shot is still a thing. And four doctors we spoke to said they recommend you get your flu shot this year.

This new option, known as FluMist, was released Friday and is the same vaccine formulation that has been available in doctors' offices for decades. Also in the news: covid, measles, and rabies.